专利检索 ap:("Pfizer Ireland Pharmaceuticals") AND inv:"Charles M. CONWAY" 第 1 页

1.

发明公开
COMPOSITIONS FOR IMPROVED DELIVERY OF CGRP INHIBITORS 审中-公开

公开(公告)号：US20240066028A1

公开(公告)日：2024-02-29

申请号：US18255949

申请日：2021-12-16

申请人： Pfizer Ireland Pharmaceuticals

发明人： Charles M. CONWAY , Gene M. DUBOWCHIK , Rajesh KUMAR

IPC分类号： A61K31/496 , A61K9/00 , A61K9/48 , A61K9/20

CPC分类号： A61K31/496 , A61K9/006 , A61K9/4858 , A61K9/2013

摘要： Provided is a pharmaceutical formulation in the form of a softgel dosage form including a calcitonin gene-related peptide (CGRP) inhibitor, a lipophilic phase, and at least one lipophilic surfactant. Also provided is a method for increasing bioavailability of a calcitonin gene-related peptide (CGRP) inhibitor in a subject, including orally administering the pharmaceutical formulation to increase the bioavailability of the CGRP inhibitor in the subject.